Search for: "State v. Janssen" Results 141 - 160 of 239
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Aug 2021, 9:35 am by Race to the Bottom
(Nasdaq, Rule 5801; Nasdaq, Rule 5830; Cory Janssen, Investopedia). [read post]
17 Feb 2012, 11:29 am by Bexis
Ortho-McNeil-Janssen Pharmaceuticals Inc., 2010 WL 3548474 (Pa. [read post]
27 Dec 2017, 5:00 am by Daniel E. Cummins
Janssen Pharmaceuticals, Inc., 2017 Pa. [read post]
14 Jan 2014, 9:30 am by Shaunna Mireau
However, in keeping with Janssen Inc v Teva (supra), I find that there is also a requirement to provide evidence that the research is relevant. [read post]
10 Apr 2014, 11:58 am
Janssen Pharmaceuticals, Inc., 2014 WL 1335511 (Pa. [read post]
19 Sep 2013, 9:53 am by Bexis
  In the consultation report of the neurologist states: “Neurontin is wholly appropriate in this patient. [read post]
5 Jul 2020, 7:58 pm by Omar Ha-Redeye
They concluded that the Deputy Judge’s reliance on Janssen-Ortho Inc. [read post]
28 May 2015, 6:02 am
Janssen Pharms., Inc., No. 1:14-CV-1025, 2015 U.S. [read post]
24 Apr 2013, 8:31 am by Rebecca Tushnet
Food & Drug Law Institute Annual Conference Top 20 Cases in Food & Drug Law in 2012 and Cases to Watch in 2013 Bill Janssen, Charleston School of Law: Weddle v. [read post]
11 Jan 2011, 11:07 pm by Kelly
General Steve Burrill makes predictions for the biotech industry in 25th annual report (Patent Docs) Australia: ‘Innovation’ patents in Australia – AMI innovation patent and US investment (IPBiz) Australia: Extension of patent term for pharmaceuticals in Australia: AAT decision in LTS Lohmann Therapie Systeme AG and Schwarz Pharma Ltd and Commissioner of Patents (Patent Baristas) US: CAFC : Single embodiment commercial success: In re Glatt Air Techniques (Patently-O) (Patents Post… [read post]
30 May 2017, 5:17 am by Howard Knopf
Janssen-Ortho Inc., 2009 FCA 212 (CanLII), where the need for explicit “acknowledgment” of the adoption of a party’s written submissions was addressed. [read post]
30 May 2017, 5:17 am by Howard Knopf
Janssen-Ortho Inc., 2009 FCA 212 (CanLII), where the need for explicit “acknowledgment” of the adoption of a party’s written submissions was addressed. [read post]
22 Mar 2011, 5:08 am by Brian A. Comer
Risperdal is different from other antipsychotic medicines and “doctors needed to know that,” he added.Jurors will begin deliberating the case tomorrow.The case is State of South Carolina v. [read post]